Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Phio Pharmaceuticals Corp. (PHIO) had Weighted-Average Shares Outstanding (Diluted) of 11.62M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-4.00M |
|
-- |
|
-- |
|
$4.17M |
|
$-4.17M |
|
$0.16M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.00M |
|
$-4.17M |
|
$-4.17M |
|
11.62M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
11.62M |
$-0.34 |
|
$-0.34 |
|
| Balance Sheet Financials | |
$17.40M |
|
$0.01M |
|
$0.01M |
|
$17.41M |
|
$0.95M |
|
-- |
|
-- |
|
$0.95M |
|
$16.46M |
|
$16.46M |
|
$16.46M |
|
11.62M |
|
| Cash Flow Statement Financials | |
$-4.00M |
|
$0.00M |
|
-- |
|
$21.03M |
|
$17.03M |
|
$-4.00M |
|
$0.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
18.32 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-24.32% |
|
-24.32% |
|
-22.99% |
|
-24.32% |
|
$1.42 |
|
$-0.34 |
|
$-0.34 |
|